Black checkmark with a sparkle and a curved line underneath on a white background.
Company

VSEE HEALTH, INC.

Ticker
VSEE
Sector
Industry
Report date
November 17, 2026
Valye AI Score

96

Very high visibility
Recent developments
Recent developments summary

Recent developments highlight VSee Health's product innovation and contract wins in telehealth and virtual care services.

Recent developments:
  • VSee launched an AI-driven rural health transformation platform aimed at enhancing healthcare delivery in rural areas [N14].
  • The company secured a major contract with a Florida health system to provide home health and telenursing services, expanding its customer base [N15].
  • VSee partnered with Tele911 to offer virtual emergency room services, broadening its telehealth service offerings [N16].
Overview

VSee Health, Inc. is a telehealth solutions provider operating primarily through its wholly-owned subsidiary VSee Lab. The company offers a comprehensive telehealth platform designed for U.S. hospitals and enterprises, featuring modular software building blocks that enable clinicians to configure telehealth workflows without programming. The platform includes patient engagement tools, clinician staffing solutions, remote physical exam capabilities, AI-enhanced nursing support, and administrative dashboards. VSee Lab integrates with major electronic medical record systems and complies with HIPAA, SOC2, and GDPR standards. Additionally, through its subsidiary iDoc, VSee provides specialty intensive care telemedicine services, connecting critically ill patients with specialized physicians across various hospital settings and correctional facilities. The company addresses key healthcare challenges such as patient engagement and clinician shortages, particularly in intensive care units. Sales efforts include direct enterprise teams and indirect channels.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. VSee Health, Inc. operates a telehealth platform through its subsidiary VSee Lab, offering configurable telehealth software building blocks for hospitals and enterprises. The platform supports patient engagement, clinician staffing, remote exams, AI-driven nursing solutions, and integrates with EMRs. The company also provides specialty ICU telemedicine services via its subsidiary iDoc. As of September 30, 2026, the company reported $1.5 million in revenue and a net loss of $2.8 million, with a current ratio of 0.29 indicating liquidity constraints [S1][S2]. Recent news highlights include launching an AI-driven rural health platform and securing a major contract with a Florida health system [N14][N15].

Scenarios for VSEE

Bull case model:

VSee Health's platform addresses critical healthcare needs by enabling flexible, clinician-configurable telehealth solutions that integrate with existing hospital systems. Its AI-driven nursing and remote monitoring capabilities offer innovative approaches to mitigate clinician shortages. The specialty ICU telemedicine services through iDoc expand its reach into high-acuity care settings. Recent contract wins and product launches, including AI-driven rural health transformation, demonstrate active market engagement and product development. The company's direct and indirect sales channels provide multiple avenues for customer acquisition and growth.

Bear case model:

The company faces liquidity challenges as indicated by a current ratio below 1 and a net loss reported in the latest quarter. The telehealth market is competitive with numerous established players, which may pressure pricing and customer retention. Dependence on healthcare enterprises for revenue exposes VSee to budget constraints and regulatory changes in the healthcare sector. Execution risks include scaling the sales organization effectively and maintaining clinical quality standards across diverse care settings. The complexity of integrating with multiple EMRs and ensuring compliance with evolving regulations may also pose operational challenges.

Moat:

VSee Health's moat is anchored in its clinician-centric, no-code configurable telehealth platform that empowers healthcare providers to tailor workflows without IT dependency, enhancing adoption and user satisfaction. Its integration capabilities with major EMRs and compliance with stringent security and privacy standards (HIPAA, SOC2, GDPR) support enterprise scalability. The company's specialty ICU telemedicine services via iDoc, combined with a comprehensive quality management program and a broad network of board-certified physicians, provide differentiated clinical offerings. The AI-driven nursing augmentation and remote patient monitoring features further enhance its competitive positioning in addressing clinician shortages and improving patient care continuity.

Risks overview
Risks summary
Liquidity constraints combined with competitive pressures and regulatory complexities represent the primary risks to VSee Health's business execution and financial stability.
Risks details:

• Liquidity Risk: The company's current ratio of 0.29 as of September 30, 2026, indicates potential short-term liquidity constraints that could impact operational flexibility [S2].
• Competitive Market: The telehealth industry is highly competitive with many established and emerging players, which may affect VSee's market share and pricing power [S1].
• Regulatory and Compliance Risks: Healthcare regulations and compliance requirements such as HIPAA, SOC2, and GDPR are complex and evolving, requiring continuous adaptation and investment [S1].
• Execution Risk: Scaling sales efforts and maintaining clinical quality across diverse healthcare settings pose operational challenges that could affect growth and reputation [S1].

FINAL FORECAST FOR VSEE

Final take one line
VSee Health provides a comprehensive telehealth platform and specialty ICU telemedicine services with strong clinician-centric features but faces liquidity and competitive challenges.
Final take 12 to 24 month view

Business trends: Increasing adoption of telehealth platforms with AI-driven nursing augmentation and specialty ICU telemedicine addressing clinician shortages and patient engagement.
Execution milestones: Expansion of product offerings including AI-driven rural health platform, securing major healthcare contracts, and enhancing virtual ER services.
Key risks: Liquidity constraints, competitive pressures in telehealth, regulatory compliance complexities, and operational execution challenges.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

96
LLM visibility overview
LLM Visibility known facts
  • VSee Health, Inc. operates through its wholly-owned subsidiary VSee Lab, offering a comprehensive telehealth platform for U.S. hospitals and enterprises [S1].
  • The telehealth platform consists of software building blocks including on-demand visits, appointment scheduling, intake forms, consent and compliance signatures, team coordination, unified communication, remote exams, remote patient monitoring, payments including insurance processing, clinical notes, and administrative dashboards [S1].
  • The platform integrates with electronic medical record systems such as EPIC and Cerner via HL7, FHIR, and sFTP, and is HIPAA compliant, SOC2 audited, GDPR compliant, and supports single-sign-on and multi-factor authentication [S1].
  • VSee Lab enables clinicians to configure telehealth workflows without programming (no code) or with simple coding (low code), empowering clinicians to customize workflows without IT dependency [S1].
  • The company offers AI-driven telesitter and telenursing solutions to augment bedside nursing staff, including remote admission/discharge, asynchronous/on-demand nursing mentoring, and AI event monitoring with multi-layer nursing coverage [S1].
  • VSee Lab supports patient engagement features such as branded waiting rooms, on-demand and scheduled visits, customizable intake forms, insurance eligibility verification, online payments, wait queue management, educational content, and live chat with front desk [S1].
  • During virtual visits, the platform supports text, audio, 1-on-1 and group video, inclusion of family members and interpreters, image/document sharing and annotation, file sending, streaming of medical devices (otoscope, stethoscope) for remote physical exams, and camera control [S1].
  • Post-visit features include scheduling follow-ups, auto-confirmations and reminders, patient access to visit notes and attachments, post-visit surveys, ePrescribe medication pickup, and insurance billing via SuperBill [S1].
  • The platform supports wellness engagement with personal health goals, device data tracking (Fitbit, scales, blood pressure cuffs), food diary and mood chart sharing, and secure messaging [S1].
  • VSee Lab offers a productive clinician experience with fast setup, provider and patient management, 250+ configurable options without programming, asynchronous eConsult workflows, appointment management, payment processing, flexible intake forms, interpreter dispatch, and EMR integration [S1].
  • The platform enables efficient team coordination with sound alerts, mobile notifications, patient tracking across waiting rooms, and internal chats with customizable visit tags [S1].
  • Administrative features include HIPAA enforcement with user roles and intrusion logging, clinician staffing and scheduling management, payment and billing setup, data dashboards for patient satisfaction and wait times, report creation and export, and call recording policies [S1].
  • Enterprise scaling features include compliance with state medical license rules, patient routing to balance clinician load, patient tagging, strong encryption, single-sign-on, multi-factor authentication, and SOC2 audit compliance [S1].
  • Through its wholly-owned subsidiary iDoc, VSee provides specialty intensive care unit services including neurology, cardiac, and medical intensive care via telemedicine, connecting critically ill patients to specialized physicians [S1].
  • iDoc serves diverse customers including large hospital systems, small/micro hospitals, long-term acute care facilities, and the federal prison system, offering e-consults in over 14 specialties [S1].
  • iDoc uses a proprietary telehealth platform integrating video conferencing, electronic health records, and billing technology, with HIPAA-compliant secure connections and encrypted data storage [S1].
  • iDoc has a comprehensive quality management program supporting evidence-based practices, customer satisfaction tracking, continuous improvement, and regular review and adaptation of clinical protocols by board-certified physicians [S1].
  • VSee's business model addresses two major U.S. healthcare challenges: improving patient engagement and addressing clinician shortages, especially in intensive care units [S1].
  • The company employs a direct sales organization segmented by customer type, including enterprise-focused teams and indirect channels such as third-party resellers and affiliated hospitals [S1].
  • Financial snapshot as of 2026-09-30 shows cash and equivalents of $41,666, current assets of $2,815,312, current liabilities of $9,585,883, resulting in a current ratio of 0.29 and a cash ratio of 0 [S2].
  • Revenue for the quarter ended 2026-09-30 was $1,496,779 with a net loss of $2,848,701 [S2].
  • Basic and diluted EPS for the quarter ended 2026-03-31 were both -$0.05 [S2].
  • Recent news includes the launch of an AI-driven rural health transformation platform by VSee [N14], a major contract win with a Florida health system for home health and telenursing services [N15], and a partnership with Tele911 for virtual ER services [N16].
Sources
Sources - Context summary

Generated 2026-11-17

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-31 | 10-K
  • S2 | 2026-11-16 | 10-Q
Sources - News headlines
  • N1 | 2026-11-17 | www.nasdaq.com | APi Group Corporation Announces Launch of €500 Million Senior Notes Offering | https://www.nasdaq.com/articles/api-group-corporation-announces-launch-eu500-million-senior-notes-offering
  • N2 | 2026-11-17 | www.nasdaq.com | Tencent Music Entertainment Group Announces Third Quarter 2026 Unaudited Financial Results | https://www.nasdaq.com/articles/tencent-music-entertainment-group-announces-third-quarter-2026-unaudited-financial-results
  • N3 | 2026-11-17 | www.nasdaq.com | German Stocks Decline On U.S. Chip Restrictions | https://www.nasdaq.com/articles/german-stocks-decline-us-chip-restrictions
  • N4 | 2026-11-17 | www.nasdaq.com | CoreWeave Answered the Biggest Question About AI Stocks. Now Nvidia Has to Confirm It. | https://www.nasdaq.com/articles/coreweave-answered-biggest-question-about-ai-stocks-now-nvidia-has-confirm-it
  • N5 | 2026-11-17 | www.nasdaq.com | Walt Disney Q4 26 Earnings Conference Call At 8:30 AM ET | https://www.nasdaq.com/articles/walt-disney-q4-26-earnings-conference-call-8-30-am-et
  • N6 | 2026-11-17 | www.nasdaq.com | Home Depot Q3 26 Earnings Conference Call At 9:00 AM ET | https://www.nasdaq.com/articles/home-depot-q3-26-earnings-conference-call-9-00-am-et
  • N7 | 2026-11-17 | www.nasdaq.com | NVIDIA Q3 27 Earnings Conference Call At 5:00 PM ET | https://www.nasdaq.com/articles/nvidia-q3-27-earnings-conference-call-5-00-pm-et
  • N8 | 2026-11-17 | www.nasdaq.com | Home Depot Announces Appointment Of Richard McPhail As CEO | https://www.nasdaq.com/articles/home-depot-announces-appointment-richard-mcphail-ceo
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine